Bayer is facing a proposed class-action lawsuit in the U.S. alleging anti-competitive practices in the genetically modified corn seed market. The lawsuit claims Bayer obstructed independent seed companies from developing competing products after its NK603 trait patent expired in 2022. Bayer has denied the allegations and plans to contest them legally. AI
RANK_REASON Lawsuit against a major company for alleged anti-competitive practices. [lever_c_demoted from significant: ic=1 ai=0.1]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
